product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human TRAILR1/TNFRSF10A Fc Chimera Protein, CF
catalog :
347-DR-100/CF
quantity :
100 ug
price :
447 USD
more info or order :
citations: 5
Reference
Kim E, Kim A. Combination effect of equol and TRAIL against human cervical cancer cells. Anticancer Res. 2013;33:903-12 pubmed
Peppa D, Gill U, Reynolds G, Easom N, Pallett L, Schurich A, et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med. 2013;210:99-114 pubmed publisher
Bellucci R, Nguyen H, Martin A, Heinrichs S, Schinzel A, Hahn W, et al. Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells. J Clin Invest. 2012;122:2369-83 pubmed publisher
Gasparian M, Chernyak B, Dolgikh D, Yagolovich A, Popova E, Sycheva A, et al. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5. Apoptosis. 2009;14:778-87 pubmed publisher
He Q, Lee D, Rong R, Yu M, Luo X, Klein M, et al. Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. Oncogene. 2002;21:2623-33 pubmed
product information
brand :
R&D Systems, a Bio-Techne Brand
catalog number base :
347-DR/CF
SKU :
347-DR-100/CF
product name :
Recombinant Human TRAILR1/TNFRSF10A Fc Chimera Protein, CF
Description :
The Recombinant Human TRAILR1/TNFRSF10A Fc Chimera Protein, CF from R&D Systems is derived from Sf 21 (baculovirus). The Recombinant Human TRAILR1/TNFRSF10A Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
TRAILR1/TNFRSF10A
category :
Proteins and Enzymes
unit size :
100 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
observed molecular weight :
46 kDa, reducing conditions
theoretical molecular weight :
43 kDa (monomer)
gene symbol :
TNFRSF10A
details of functionality :
Measured by its ability to inhibit TRAIL-mediated cytotoxicity using L-929 mouse fibroblast cells treated with TRAIL. The ED50 for this effect is 1-3 ng/mL in the presence of 6 ng/mL of Recombinant Human TRAIL/TNFSF10 (Catalog # 375-TEC).
endotoxin note :
<0.01 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
AAC51226
applications :
Bioactivity
source :
Sf 21 (baculovirus)-derived Recombinant Human TRAILR1/TNFRSF10A Fc Chimera Protein
extended description :
A New rh TRAIL R1 is Now Available! ~2 fold better activity; CHO expressed; No his tag!
USD :
447 USD
product details :
A New rh TRAIL R1 is Now Available! ~2 fold better activity; CHO expressed; No his tag!
alt names :
APO2, CD261, CD261 antigen, cytotoxic TRAIL receptor, Death receptor 4, DR4, DR4 TRAIL receptor 1, TNF-related apoptosis inducing ligand receptor 1, TNF-related apoptosis-inducing ligand receptor 1, TNFRSF10A, TRAIL R1, TRAIL-R1, TRAILR-1, TRAILR1MGC9365, tumor necrosis factor receptor superfamily member 10A, tumor necrosis factor receptor superfamily, member 10a
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.